Literature DB >> 11673837

Cathepsin K--a marker of macrophage differentiation?

F Bühling1, A Reisenauer, A Gerber, S Krüger, E Weber, D Brömme, A Roessner, S Ansorge, T Welte, C Röcken.   

Abstract

Cathepsin K is a cysteine protease with high matrix-degrading activity. Initially, cathepsin K was described as being expressed exclusively by osteoclasts. It was suggested that cathepsin K expression is a specific feature of cells involved in bone remodelling. The aim of this study was to investigate the hypothesis that cathepsin K is expressed not only in bone-resorbing macrophages, but also more generally in specifically differentiated macrophages, such as epithelioid cells and multinucleated giant cells in soft tissues. Specimens obtained from different organs and anatomical locations of patients suffering from sarcoidosis, tuberculosis, granulomas caused by foreign materials, and sarcoid-like lesions were investigated for the expression of cathepsins B, K, and L. Immunohistochemistry and in situ hybridization showed cathepsin K in epithelioid cells and multinucleated giant cells irrespective of the pathological condition and anatomical location, but not in normal resident macrophages. By immunoelectron microscopy, cathepsin K was discovered in cytoplasmic granules of multinucleated giant cells. In contrast, cathepsin B and cathepsin L were expressed ubiquitously in CD68-positive tissue macrophages, epithelioid cells, and multinucleated giant cells. The results demonstrate that cathepsin K, but not cathepsin B or cathepsin L, differentiates specific phenotypes of macrophages independently of the anatomical site. Its enzymatic characteristics, particularly its high matrix-degrading activity, suggest that cathepsin K-positive epithelioid cells and multinucleated giant cells are characterized by an enhanced specific proteolytic capability. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673837     DOI: 10.1002/path.959

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  30 in total

1.  Macrophage cathepsin K promotes prostate tumor progression in bone.

Authors:  M K Herroon; E Rajagurubandara; D L Rudy; A Chalasani; A L Hardaway; I Podgorski
Journal:  Oncogene       Date:  2012-05-21       Impact factor: 9.867

2.  Retinoic acid-induced premature osteoblast-to-preosteocyte transitioning has multiple effects on calvarial development.

Authors:  Shirine Jeradi; Matthias Hammerschmidt
Journal:  Development       Date:  2016-02-22       Impact factor: 6.868

3.  Photoactivated inhibition of cathepsin K in a 3D tumor model.

Authors:  Mackenzie K Herroon; Rajgopal Sharma; Erandi Rajagurubandara; Claudia Turro; Jeremy J Kodanko; Izabela Podgorski
Journal:  Biol Chem       Date:  2016-06-01       Impact factor: 3.915

4.  Gene expression profiles reveal increased mClca3 (Gob5) expression and mucin production in a murine model of asbestos-induced fibrogenesis.

Authors:  Tara Sabo-Attwood; Maria Ramos-Nino; Jeffrey Bond; Kelly J Butnor; Nicholas Heintz; Achim D Gruber; Chad Steele; Douglas J Taatjes; Pamela Vacek; Brooke T Mossman
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

5.  Probing cathepsin K activity with a selective substrate spanning its active site.

Authors:  Fabien Lecaille; Enrico Weidauer; Maria A Juliano; Dieter Brömme; Gilles Lalmanach
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

6.  Human macrophage foam cells degrade atherosclerotic plaques through cathepsin K mediated processes.

Authors:  Natasha Barascuk; Helene Skjøt-Arkil; Thomas C Register; Lise Larsen; Inger Byrjalsen; Claus Christiansen; Morten A Karsdal
Journal:  BMC Cardiovasc Disord       Date:  2010-04-21       Impact factor: 2.298

7.  Structural and functional relationships in the virulence-associated cathepsin L proteases of the parasitic liver fluke, Fasciola hepatica.

Authors:  Colin M Stack; Conor R Caffrey; Sheila M Donnelly; Amritha Seshaadri; Jonathan Lowther; Jose F Tort; Peter R Collins; Mark W Robinson; Weibo Xu; James H McKerrow; Charles S Craik; Sebastian R Geiger; Rachel Marion; Linda S Brinen; John P Dalton
Journal:  J Biol Chem       Date:  2007-12-26       Impact factor: 5.157

8.  A broad survey of cathepsin K immunoreactivity in human neoplasms.

Authors:  Gang Zheng; Guido Martignoni; Cristina Antonescu; Elizabeth Montgomery; Charles Eberhart; George Netto; Janis Taube; William Westra; Jonathan I Epstein; Tamara Lotan; Anirban Maitra; Edward Gabrielson; Michael Torbenson; Christine Iacobuzio-Donahue; Angelo Demarzo; Ie Ming Shih; Peter Illei; T C Wu; Pedram Argani
Journal:  Am J Clin Pathol       Date:  2013-02       Impact factor: 2.493

9.  ApoE-deficient mice on cholate-containing high-fat diet reveal a pathology similar to lung sarcoidosis.

Authors:  Andriy O Samokhin; Frank Bühling; Franz Theissig; Dieter Brömme
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

10.  Cathepsin K: a cysteine protease with unique kinin-degrading properties.

Authors:  Emmanuel Godat; Fabien Lecaille; Claire Desmazes; Sophie Duchêne; Enrico Weidauer; Paul Saftig; Dieter Brömme; Christophe Vandier; Gilles Lalmanach
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.